Marc Engelbrecht

University of Amsterdam

Papers

1

Total Citations

14

H-Index

1

About

Marc Engelbrecht is a leading researcher in the field of interventional oncology, with a primary focus on the development and evaluation of focal therapies for prostate cancer. His key research areas include magnetic resonance imaging (MRI) and contrast-enhanced ultrasound (CEUS) for treatment monitoring, as well as the optimization of transperineal focal laser ablation (TPLA). Engelbrecht’s major contribution lies in pioneering reliable visualization techniques to assess the treatment effect of TPLA, a minimally invasive modality with low morbidity. His 2023 work, which has garnered 14 citations, addresses the critical gap in dosimetry modeling by establishing a three-dimensional, histologically defined ablation zone for both single- and multi-fiber applications. This advancement enhances the precision and safety of prostate cancer treatments, offering a pathway to more personalized care. Engelbrecht’s research is highly impactful, bridging imaging science and clinical oncology to improve patient outcomes. His notable achievements include advancing the translational application of multimodal imaging, positioning him as a key figure in the evolution of focal ablative therapies.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Reliable Visualization of the Treatment Effect of Transperineal Focal Laser Ablation in Prostate Cancer Patients by Magnetic Resonance Imaging and Contrast-enhanced Ultrasound Imaging
14 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: University of Amsterdam

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago